PolarCool sign a distributor agreement for the Australian market
The medical technology company PolarCool AB (publ.) has signed a distributor agreement with sports technology company eo for the Australian market. The agreement follows the recent TGA market approval for PolarCap® System in Australia.
PolarCool develops the product PolarCap®, which alleviates the effects of concussions. The primary customers are sports clubs and facilities in ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.
eo are an Australian sports technology company, focused on enhancing athletic performance through innovative sports science and technology. The company has a broad expertise in sports technology, a deep market knowledge, and extensive network within the Australian sports industry. Additionally, eo's proven track record of successfully launching and scaling sports technology products ensures effective market penetration and growth for PolarCap® System in Australia.
PolarCool CEO Erik Andersson comments:
-We are delighted to announce our partnership with eo as our distributor for the Australian market. Our companies share similar values and missions, making this collaboration a perfect fit. Enabling us to enter the Australian market marks a significant milestone for PolarCool’s international expansion and aligns with our short-term goal of becoming profitable.
The Australian sports market has been of particular interest to PolarCool due to the prevalence of contact sports played in the country. For the past 18 months, PolarCool has held a TGA Medical exemption agreement with the rugby league team, Manly Warringah Sea. The exemption has enabled their leading team doctor, Dr. Paul Bloomfield, to provide PolarCap® System to the team, and also to introduce it to other teams in the top Australian National Rugby League (NRL).
